06.12.2020, 2206 Zeichen

Vienna Insurance Group: Vienne Insurance Group AG Wiener Versicherung Gruppe (VIG) agreed with Aegon N.V. to acquire Aegon's insurance business in Hungary, Poland, Romania and Turkey. VIG will take over Aegon's non-life and life insurance companies as well as pension funds, asset management and service companies in these countries, which ideally complement VIG's existing portfolio. The purchase price amounts to Euro 830 mn. The transaction is subject to the necessary regulatory and competition approvals. Closing of the transaction is expected to take place in the second half of 2021.
VIG: weekly performance: 1.83%

Lenzing: Fibers producer Lenzing AG has successfully issued a hybrid bond – a subordinated, unsecured bond – with a total volume of Euro 500 mn and a coupon of 5.75 percent. The bond was multiple times oversubscribed, has a perpetual tenor and achieves 100 percent IFRS equity accounting due to its structural features. It has successfully been issued following a two-day roadshow with international investors. The denomination of the hybrid bond is Euro 100,000.
Lenzing: weekly performance: 1.10%

Marinomed Biotech: Marinomed Biotech AG, a globally operating biopharmaceutical company, announced that the Swansea University Medical School plans a clinical trial with Iota-/kappa-carrageenan nasal spray as a COVID-19 Prophylaxis for Healthcare Professionals (ICE-COVID). The investigator-initiated trial at Swansea will be recruiting 480 healthcare professionals managing COVID-19 patients during the pandemic. Objective of the study is to assess the efficacy of Carragelose nasal and throat spray in reducing the rate, severity, and duration of COVID-19 infections. Further endpoints include infection with other respiratory viruses, usability of the spray for prophylaxis and the effects on quality adjusted life years (QALYs). The ongoing clinical trial is supported by Marinomed Biotech AG, the originator and licensor of Carragelose and Boots UK; the Carragelose nasal spray used in the study is marketed as Boots Dual Defence in the United Kingdom.
Marinomed Biotech: weekly performance: 0.84%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (30/11/2020)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1149: ATX zum 35er der 1. Veröffentlichung in den Tageszeitungen auf Rekordniveau; CCPA-Chefs gratulieren

Bildnachweis

Aktien auf dem Radar:Flughafen Wien, Telekom Austria, Polytec Group, Lenzing, CPI Europe AG, voestalpine, AT&S, Andritz, Verbund, Athos Immobilien, Bawag, DO&CO, Erste Group, FACC, Frequentis, Gurktaler AG Stamm, Marinomed Biotech, Porr, Rath AG, RBI, SBO, Uniqa, VIG, Wienerberger, Rosenbauer, Semperit, BKS Bank Stamm, Oberbank AG Stamm, Amag, CA Immo, EuroTeleSites AG.

---